Stock-Based Compensation

9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

Note 7 — Stock-Based Compensation

Stock-based compensation for continuing operations consisted of the following:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In millions)	2019		2018		2019		2018
Stock-based compensation expense	$	—	$	—	$	—	$	(0.3	)

We have stock-based compensation awards consisting of stock options, restricted stock and stock appreciation rights under four plans (collectively, the “Stock Plans”) which are described in detail in our Annual Report on Form 10-K for the year ended December 31, 2018. As of September 30, 2019, there were 315,251 shares available for grant under the 2011 Incentive Plan. No further shares were available for grant under any other stock incentive plan.

Stock Options

The following table summarizes our stock option activity:

	Stock Options			Weighted Average Exercise Price
Outstanding December 31, 2018		113		$	16,734.00
Canceled		(113	)		16,734.00
Outstanding September 30, 2019		—		$	—
Exercisable as of September 30, 2019		—		$	—

The weighted average assumptions used in the valuation of options are not applicable for the periods ending September 30, 2019 and 2018 as no options were granted over this time.

As of September 30, 2019, there was no unrecognized compensation expense related to non-vested stock options granted under our Stock Plans.

Restricted Stock

The following table summarizes our restricted stock activity:

	Restricted Stock			Weighted Average Grant Date Fair Value Per Share
Nonvested as of December 31, 2018		150		$	1,406.00
Granted		—			—
Vested		(75	)		1,406.00
Forfeited		(75	)		1,406.00
Nonvested as of September 30, 2019		—		$	—

The cost of the awards is determined using the fair value of the Company’s common stock on the date of the grant, and compensation is recognized on a straight-line basis over the requisite vesting period.

As of September 30, 2019, the company did not have any unrecognized compensation expense related to non-vested restricted stock granted under our Stock Plans.